Cargando…
Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review
BACKGROUND: Traditionally, within dose-finding clinical trials, treatment toxicity and tolerability are assessed by clinicians. Research has shown that clinician reporting may have inadequate inter-rater reliability, poor correlation with patient reported outcomes, and under capture the true toxicit...
Autores principales: | Alger, Emily, Minchom, Anna, Lee Aiyegbusi, Olalekan, Schipper, Matthew, Yap, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541462/ https://www.ncbi.nlm.nih.gov/pubmed/37781154 http://dx.doi.org/10.1016/j.eclinm.2023.102228 |
Ejemplares similares
-
Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum
por: Lai-Kwon, Julia, et al.
Publicado: (2022) -
Trends in patient‐reported outcome use in early phase dose‐finding oncology trials – an analysis of ClinicalTrials.gov
por: Lai‐Kwon, Julia, et al.
Publicado: (2021) -
Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review
por: Villacampa, Guillermo, et al.
Publicado: (2023) -
Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013) -
Key methodological considerations for usability testing of electronic patient-reported outcome (ePRO) systems
por: Aiyegbusi, Olalekan Lee
Publicado: (2019)